Putnam Investments’s Pacific Biosciences PACB Stock Holding History

Putnam Investments’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$400K	Buy	40,752 +402	+1%	+$3.29K	﹤0.01%	1001
2023 Q3	$337K	Sell	40,350 -348	-0.9%	-$3.98K	﹤0.01%	1040
2023 Q2	$541K	Sell	40,698 -1,268	-3%	-$15.4K	﹤0.01%	915
2023 Q1	$486K	Buy	+41,966	New	+$417K	﹤0.01%	946
2022 Q1	–	Sell	-139,254	Closed	-$2.85M	–	1236
2021 Q4	$2.85M	Buy	139,254 +8,390	+6%	+$202K	﹤0.01%	702
2021 Q3	$3.34M	Sell	130,864 -32	-0%	-$948	0.01%	652
2021 Q2	$4.58M	Buy	130,896 +57,381	+78%	+$1.67M	0.01%	533
2021 Q1	$2.45M	Buy	+73,515	New	+$2.57M	﹤0.01%	651

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Putnam Investments's PACB Position: Q4 2023 in Review

Putnam Investments increased its Pacific Biosciences (PACB) stake by 1% in Q4 2023, buying an estimated $3.29K and bringing the position to 40,752 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Putnam Investments first reported a position in PACB in Q1 2021 and has held it in 8 quarters since. The position peaked at $4.58M in Q2 2021. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

Putnam Investments held 40,752 shares of Pacific Biosciences worth $400K as of Q4 2023.
Putnam Investments bought 402 Pacific Biosciences shares in Q4 2023, an estimated $3.29K.
Pacific Biosciences made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1001 holding.
Putnam Investments first reported a position in Pacific Biosciences in Q1 2021 and has held it in 8 quarters since.
Putnam Investments's Pacific Biosciences position peaked at $4.58M in Q2 2021.
274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.